当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
OCTAPLAS, Pooled Plasma (Human), Solvent/Detergent Treated
申请企业
Octapharma Pharmazeutika Produktionsges.m.b.H.
药品名称
OCTAPLAS, Pooled Plasma (Human), Solvent/Detergent Treated
承诺描述
A non-interventional, open-label, multicenter, clinical study to investigate safety, tolerability and efficacy of Octaplas™ in the management of pediatric patients less than 16 years old who require therapeutic plasma exchange
承诺状态描述
Per FDA letter dated February 25, 2021, this PMR has been fulfilled.